<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04250558</url>
  </required_header>
  <id_info>
    <org_study_id>D20046</org_study_id>
    <nct_id>NCT04250558</nct_id>
  </id_info>
  <brief_title>ICG Fluorescence Imaging in Lower Extremity Amputation Patients</brief_title>
  <official_title>Indocyanine Green Fluorescence Guided Imaging in Lower Extremity Amputation Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-randomized prospective study of 30 patients scheduled to undergo lower
      extremity amputation (below the knee, through the knee or above the knee) evaluating bone
      perfusion and viability using indocyanine green (ICG) fluorescence imaging at several steps
      during surgical procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a non-randomized prospective study of 30 patients scheduled to undergo lower
      extremity amputation (below the knee, through the knee or above the knee) evaluating bone
      perfusion and viability using indocyanine green (ICG) fluorescence imaging at several steps
      during surgical procedure. The data collected in this study will inform the development of
      methodology and thresholds around providing surgeons with objective data regarding critically
      injured bone in the setting of musculoskeletal trauma and/or bone infection. This will
      improve our management of and decrease variation associated with management of these
      disabling conditions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total Bone Blood Flow (TBBF)</measure>
    <time_frame>4 hours</time_frame>
    <description>Changes to total bone blood flow changes that occur as a result of osteotomy and soft tissue stripping associated with the amputationas will be assessed by immunofluorescence based dynamic constrast enhanced fluorescence imaging.</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Trauma Injury</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lower Extremity Amputation</intervention_name>
    <description>patients 18 years of age or older who will have a planned lower leg (either below knee, through knee, or above knee) amputation surgery are scheduled to undergo a lower extremity amputation (either below knee, through knee or above knee), performed by a participating surgeon or delegate. Provision of informed consent.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients 18 years of age or older who present to DHMC and are scheduled to
        undergo a lower extremity amputation (either below knee, through knee or above knee) will
        be considered for study enrollment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients 18 years of age or older

          2. Scheduled for a lower extremity amputation (either below knee, through knee or above
             knee)

          3. Provision of informed consent

        Exclusion Criteria:

          1. Iodine allergy

          2. Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ida l gitajm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy E Hall, MS</last_name>
    <phone>6036533306</phone>
    <email>amy.e.hall@hitchcock.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rebecca E Dabrowski</last_name>
    <phone>603-653-3306</phone>
    <email>rebecca.e.dabrowski@hitchock.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ida L Gitajn, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 30, 2020</study_first_submitted>
  <study_first_submitted_qc>January 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2020</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Ida Leah Gitajn</investigator_full_name>
    <investigator_title>Staff Physician</investigator_title>
  </responsible_party>
  <keyword>Trauma</keyword>
  <keyword>Amputation</keyword>
  <keyword>Orthopaedic</keyword>
  <keyword>Lower Extremity</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

